17 studies found for:    14523139 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions
Conditions: Stable Angina;   Unstable Angina
Interventions: Device: Drug Coated Balloon;   Device: Bare Metal Stent
2 Active, not recruiting A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study
Condition: Coronary Artery Disease
Interventions: Device: Resolute Integrity Stent;   Device: Biomatrix stent
3 Recruiting Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Conditions: Coronary Artery Disease;   Coronary Disease;   Coronary Stenosis
Intervention: Device: Hybrid sirolimus- and everolimus-eluting stents (ORSIRO, XIENCE PRIME)
4 Recruiting BES, EES, and ZES-R in Real World Practice
Condition: Coronary Artery Disease
Interventions: Device: Biolimus-eluting stent;   Device: Everolimus-eluting stent;   Device: Zotarolimus-eluting stent
5 Completed In-stent Restenosis in Patients With Patent Previous Bare Metal Stent
Condition: In-stent Coronary Artery Restenosis
Intervention:
6 Active, not recruiting e-NOBORI Observational Registry of Nobori DES
Condition: Coronary Artery Disease
Intervention:
7 Enrolling by invitation NIH Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal
Condition: Coronary Restenosis
Intervention:
8 Completed
Has Results
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Conditions: Coronary Heart Disease;   Coronary Restenosis
Interventions: Drug: Oral sirolimus;   Device: Drug Eluting stent
9 Completed Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions
Conditions: Coronary Artery Disease;   Coronary Disease;   Coronary Stenosis
Intervention: Device: sirolimus-eluting stent, zotarolimus-eluting stent
10 Completed Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)
Condition: Coronary Heart Disease
Interventions: Device: rapamycin plus 17beta estradiolvalerat-eluting stent;   Device: rapamycin-eluting stent
11 Completed Rotational Atherectomy Prior to Taxus Stent
Condition: Complex Calcified Coronary Lesions
Interventions: Procedure: Rotational Atherectomy + PES;   Procedure: Standard Treatment (PES without Rotational Atherectomy)
12 Completed ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial
Condition: Coronary Occlusions
Intervention: Device: Cypher sirolimus eluting coronary stent
13 Completed Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)
Condition: Coronary Heart Disease
Interventions: Device: rapamycin-eluting Stent with permanent polymer;   Device: rapamycin-eluting stent with biodegradable polymer;   Device: polymer-free, rapamycin-eluting stent
14 Completed Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions
Conditions: Coronary Artery Disease;   Coronary Disease;   Coronary Stenosis
Intervention: Device: sirolimus-eluting stent
15 Completed Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)
Condition: Coronary Artery Disease
Interventions: Device: CYPHER Sirolimus-Eluting Stent;   Device: Uncoated BX VELOCITY Balloon-Expandable Stent
16 Unknown  GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions
Condition: Coronary Artery Disease
Intervention: Device: Coronary placement of bare metal stent vs. drug eluting stent
17 Completed Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)
Condition: Coronary Disease
Interventions: Device: Sirolimus-eluting stent (Cypher);   Device: Paclitaxel-eluting stent (Taxus)

Indicates status has not been verified in more than two years